摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,5-ditertbutylpyrazol-1-ylmethyl)-pyridine | 1137672-15-1

中文名称
——
中文别名
——
英文名称
2-(3,5-ditertbutylpyrazol-1-ylmethyl)-pyridine
英文别名
2-[(3,5-Ditert-butylpyrazol-1-yl)methyl]pyridine
2-(3,5-ditertbutylpyrazol-1-ylmethyl)-pyridine化学式
CAS
1137672-15-1
化学式
C17H25N3
mdl
——
分子量
271.406
InChiKey
YAMGAUCUPRGVTI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    30.7
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    zinc(II) nitrate hexahydrate2-(3,5-ditertbutylpyrazol-1-ylmethyl)-pyridine甲醇 为溶剂, 反应 15.0h, 以32%的产率得到[2-(3,5-ditertbutylpyrazol-1-ylmethyl)pyridine-dinitro]zinc(II)
    参考文献:
    名称:
    螯合(吡唑基甲基)吡啶配体:与锌(II)和镉(II)阳离子的配位化学和结合性能
    摘要:
    2-(3,5-二甲基吡唑-1-基甲基)吡啶(L2)和2-(3,5-二叔丁基吡唑-1-基甲基)吡啶(L3)与Zn(NO 3)或Cd(NO 3)的反应生产的单金属配合物[Zn(NO 3)2(L2)](1),[Zn(NO 3)2(L3)](2),[Cd(NO 3)2(L2)](3)和[Cd (NO 3)2(L3)](4)。在复合物的固态结构中1在图3,图4和图4中,L 2和L 3以二齿方式连接至锌和镉原子。吡唑基化合物2-(吡唑-1-基甲基)吡啶(L1),(L2)和(L3)还用作模型螯合剂,用于液-液去除锌(II),镉(II)和铅(II) )使用二氯甲烷作为有机溶剂从水中得到的阳离子。L1 - L3对锌(II)的提取效率为70-88%,对铅(II)的提取效率为50-55%,对镉(II)的提取效率为(19-31%)。从密度泛函理论计算获得的理论结果与实验提取趋势一致。
    DOI:
    10.1016/j.ica.2012.07.005
  • 作为产物:
    描述:
    2-氯甲基吡啶盐酸盐3,5-二叔丁基-1H-吡唑sodium hydroxide四丁基溴化铵 作用下, 以 为溶剂, 反应 18.0h, 以80%的产率得到2-(3,5-ditertbutylpyrazol-1-ylmethyl)-pyridine
    参考文献:
    名称:
    (Pyrazol-1-ylmethyl)pyridine palladium complexes: Synthesis, molecular structures, and activation of small molecules
    摘要:
    Reactions of 2-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L1) and 2-(3,5-di-tert-butylpyrazol-1-ylmethyl)pyridine (L2) with either [PdClMe(COD)] or [PdCl2(COD)] gave the mononuclear palladium complexes [PdCl2(L1)] (1), [PdClMe(L1)] (2) [PdCl2(L2)] (3) and [PdClMe(L2)] (4) in good yields. All compounds were characterized by NMR spectrometry, mass spectrometry, elemental analyses and also by single crystal X-ray crystallography for complexes 1, 3, and 4. The reaction of 2 with NaBAr4 in NCMe gave the salt, [[PdMeNCMe(L3)] BAr4 (5), in good yield. This salt was used as a catalyst to oligomerize ethylene at high pressures to branched polyethylene, but catalytic activity was low. The reaction of 2 with SO2 and CO formed the respective insertion products [PdClS(O)(2)Me(L1)] (6) and [PdClC(O) Me(L1)] (7). (C) 2008 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.jorganchem.2008.12.043
点击查看最新优质反应信息

文献信息

  • (Pyrazol-1-ylmethyl)pyridine Nickel Complexes: Ethylene Oligomerization and Unusual Friedel−Crafts Alkylation Catalysts
    作者:Stephen O. Ojwach、Ilia A. Guzei、Letitia L. Benade、Selwyn F. Mapolie、James Darkwa
    DOI:10.1021/om8006322
    日期:2009.4.13
    The reactions of 2,6-bis(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L1) and 2,6-bis(3,5-di-tert-butylpyrazol-1-ylmethyl)pyridine (L2) with NiCl2 or NiBr2 gave the nickel(II) complexes [NiCl2(L1)] (1), [NiBr2(L1)] (2), [NiCl2(L2)] (3), and [NiBr2(L2)] (4) in high yields. Compounds 2-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L3) and 2-(3,5-di-tert-butylpyrazol-1-ylmethyl)pyridine (L4) on the other hand
    2,6-双(3,5-二甲基吡唑-1-基甲基)吡啶(L1)和2,6-双(3,5-二叔丁基吡唑-1-基甲基)吡啶L2)2或NiBr 2生成(II)络合物[NiCl 2(L1)](1),[NiBr 2(L1)](2),[NiCl 2(L2)](3)和[NiBr 2(L2))](4)高产。化合物2-(3,5-二甲基吡唑-1-基甲基)吡啶(L3)和2-(3,5-二叔丁基另一方面,取决于吡唑基单元上取代基的空间体积,-丁基吡唑-1-基甲基)吡啶(L4)产生单核或双核(II)配合物。而L3,得到双核配合物[2(μ 2 -Cl)22(L3)2 ](5)和[2(μ 2 -Br)22(L3)2 ](6),L4,得到单核络合物[NiCl 2(L4)](7)和[NiBr 2(L4)](8)。的活化1 - 8与EtAlCl 2导致乙烯低聚至C 4,C 6和C 8支链烯烃,然后将甲苯溶剂的后续的Friedel-Crafts烷基化反应。在40
  • (Pyrazolylmethyl)pyridine platinum(II) and gold(III) complexes: Synthesis, structures and evaluation as anticancer agents
    作者:Tebogo V. Segapelo、Ilia A. Guzei、Lara C. Spencer、Werner E Van Zyl、James Darkwa
    DOI:10.1016/j.ica.2009.02.046
    日期:2009.7
    Reactions of 2-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L1), 2-(3,5-diphenylpyrazol-1-ylmethyl)pyridine (L2), 2-(3,5-di-tert-butylpyrazol-1-ylmethyl)pyridine (L3) and 2-(3-p-tolylpyrazol-1-ylmethyl)pyridine (L4) with K-2[PtCl4] in a mixture of ethanol and water formed the dichloro platinum complexes [PtCl2(L1)] (1), [PtCl2(L2)] (2), [PtCl2(L3)] (3) and [PtCl2(L4)] (4). Complex 1, [PtCl2(L1)], could also be prepared in a mixture of acetone and water. Performing the reactions of L2 and L3 in a mixture of acetone and water, however, led to C-H activation of acetone under mild conditions to form the neutral acetonyl complexes [Pt(CH2COCH3) Cl(L2)] (2a) and [Pt(CH2COCH3) Cl(L3)] (3a). The same ligands reacted with HAuCl4 center dot 4H(2)O in a mixture of ethanol and water to form the gold salts [AuCl2(L1)][AuCl4] (5) [AuCl2(L2)][Cl] (6) [AuCl2(L3)][Cl] (7) and [AuCl2(L4)][AuCl4] (8); however, with the pyrazolyl unit in the para position of the pyridinyl ring in 4-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L5), 4-(3,5-diphenylpyrazol-1-ylmethyl)pyridine (L6) neutral gold complexes [AuCl3(L5)] (9) and [AuCl2(L6)] (10) were formed; signifying the role the position of the pyrazolyl group plays in product formation in the gold reactions. X-ray crystallographic structural determination of L6, 2, 3 3a, 8 and 10 were very important in confirming the structures of these compounds; particularly for 3a and 8 where the presence of the acetonyl group confirmed C-H activation and for 8 where the counter ion is AuCl4-. Cytotoxicity studies of L2, L4 and complexes 1-10 against HeLa cells showed the Au complexes were much less active than the Pt complexes. (C) 2009 Elsevier B. V. All rights reserved.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-